Literature DB >> 1564518

Striatal degeneration and spongy myelinopathy in glutaric acidemia.

D Soffer1, N Amir, O N Elpeleg, J M Gomori, R S Shalev, S Gottschalk-Sabag.   

Abstract

The neuropathological findings in a 6 1/2-year-old boy with glutaric acidemia (GA) are described, and the pathology of 7 additional literature cases is briefly reviewed. Bilateral striatal degeneration and spongy change of the white matter were the salient features in this case and seem to represent the cardinal pathological features of the disease. Spongy myelinopathy was the result of intramyelinic vacuolation due to splitting of the myelin sheath along the intraperiod line, as illustrated here for the first time in GA. Based on morphological, biochemical and pharmacological data from humans and experimental animals, it is hypothesized that excitotoxin-mediated neuronal damage may account for the striatal degeneration, while toxic effect on myelin metabolism by the metabolic derangement of GA may explain the widespread white matter changes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1564518     DOI: 10.1016/0022-510x(92)90289-w

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

1.  Glutaric aciduria type I: pathomechanisms of neurodegeneration.

Authors:  K Ullrich; B Flott-Rahmel; P Schluff; U Musshoff; A Das; T Lücke; R Steinfeld; E Christensen; C Jakobs; A Ludolph; A Neu; R Röper
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 2.  Challenges for basic research in glutaryl-CoA dehydrogenase deficiency.

Authors:  S Kölker; K A Strauss; S I Goodman; G F Hoffmann; J G Okun; D M Koeller
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

3.  (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites.

Authors:  Inga Harting; Nikolas Boy; Jana Heringer; Angelika Seitz; Martin Bendszus; Petra J W Pouwels; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2015-04-10       Impact factor: 4.982

Review 4.  Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency.

Authors:  S Kölker; D M Koeller; S Sauer; F Hörster; M A Schwab; G F Hoffmann; K Ullrich; J G Okun
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

5.  Preliminary attempts to establish a rat model of striatal injury in glutaric acidaemia type I.

Authors:  C B R Funk; A N Prasad; M R Del Bigio
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 6.  Maintenance treatment of glutaryl-CoA dehydrogenase deficiency.

Authors:  C Mühlhausen; G F Hoffmann; K A Strauss; S Kölker; J G Okun; C R Greenberg; E R Naughten; K Ullrich
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

7.  Animal models for glutaryl-CoA dehydrogenase deficiency.

Authors:  D M Koeller; S Sauer; M Wajner; C F de Mello; S I Goodman; M Woontner; C Mühlhausen; J G Okun; S Kölker
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

8.  Promotion of oxidative stress by 3-hydroxyglutaric acid in rat striatum.

Authors:  A Latini; K Scussiato; G Leipnitz; C S Dutra-Filho; M Wajner
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

9.  Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models-a cohort study in 180 patients.

Authors:  Sven F Garbade; Cheryl R Greenberg; Mübeccel Demirkol; Gülden Gökçay; Antonia Ribes; Jaume Campistol; Alberto B Burlina; Peter Burgard; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2014-05-09       Impact factor: 4.982

10.  Long Lasting High Lysine Diet Aggravates White Matter Injury in Glutaryl-CoA Dehydrogenase Deficient (Gcdh-/-) Mice.

Authors:  Silvia Olivera-Bravo; Bianca Seminotti; Eugenia Isasi; César A Ribeiro; Guilhian Leipnitz; Michael Woontner; Stephen I Goodman; Diogo Souza; Luis Barbeito; Moacir Wajner
Journal:  Mol Neurobiol       Date:  2018-05-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.